鸡西95场(鸡西煤矿固定资产投资计划达95场)

2024-04-25 00:13:59 | 来源:心余力绌新闻网
小字号

鸡西95场(鸡西煤矿固定资产投资计划达95场)

鸡西是中国重要的煤炭资源基地之一,拥有众多煤矿资源。其中,鸡西95场是一项重大的固定资产投资计划,旨在提高矿井的生产能力和效率,进一步促进煤炭产业的发展。

煤矿固定资产投资计划

鸡西95场的固定资产投资计划主要涵盖以下几个方面:

1. 矿井设备更新:矿井设备是保证矿井正常生产运行的重要保障。通过更新设备,提高设备的自动化程度和生产效率,可以有效降低生产成本,提高煤炭的采选率。

2. 工作面掘进:煤炭的开采需要通过掘进工作面进行。在95场的固定资产投资计划中,将加大对工作面的掘进力度,增加煤炭产能,提高生产效率。

3. 安全设施建设:煤矿安全一直是行业的重点关注领域。固定资产投资计划中将包括建设和完善安全设施,提高矿井的安全性和防灾能力。

4. 环保设备升级:煤炭产业对环境的影响一直备受争议。固定资产投资计划将配套进行环保设备的升级和改造,减少煤炭开采过程中的污染物排放,达到环境保护的要求。

投资计划的意义

鸡西95场的固定资产投资计划具有重要的意义:

1. 促进煤炭产业升级:通过更新设备和提高生产效率,可以促进鸡西煤炭产业的升级和转型,提高整个产业链的竞争力。

2. 提高安全生产水平:通过加大对安全设施和防灾能力的投入,可以提高矿井的安全性,减少事故发生的风险,保障矿工的生命安全。

3. 保护环境和可持续发展:环保设备升级和污染物排放的减少,可以降低煤炭产业对环境的影响,保护生态环境,实现可持续发展。

投资计划的预期效果

预计鸡西95场的固定资产投资计划将取得以下效果:

1. 生产能力提升:通过设备更新和工作面掘进,煤炭的产能将大幅度提高,满足市场需求,增加企业的盈利能力。

2. 成本降低:设备自动化和生产效率的提高将带来成本的降低效果,提高企业的竞争力,增加利润空间。

3. 安全生产水平提高:投资于安全设施建设,将有效减少事故的发生,提高矿工的工作安全水平,保护矿工的生命安全。

4. 环境保护效果明显:环保设备的升级和污染物排放的减少,将降低煤炭产业对环境的影响,改善周边环境质量。

鸡西95场的固定资产投资计划将为煤炭产业的发展带来新的契机,提高鸡西的地位和竞争力,推动煤炭产业的转型升级和可持续发展。


(责编:admin)

分享让更多人看到

 木渎花苑街还能玩吗(木渎花苑街仍值得游玩吗?)

木渎花苑街还能玩吗(木渎花苑街仍值得游玩吗?)

2024-04-25 00:17:00 | 来源:的格真购新闻网
小字号

木渎花苑街还能玩吗?

木渎花苑街是中国江苏省苏州市木渎镇的一个古老街区,以其悠久的历史和独特的文化景观而闻名。随着时间的推移,这个古老的街区是否仍然值得游客来探索呢?让我们来看一看。

悠久的历史和独特的文化景观

木渎花苑街的历史可以追溯到南宋时期,已有近千年的历史。街区中保存着许多具有历史意义的古建筑和文物,如温家大院、桃花坞等。这些建筑展示了江南地区独特的建筑风格和文化传统。

此外,在木渎花苑街中还能看到一些传统的手工艺店铺,如木渎剪纸、木渎印花等。这些传统手工艺的技艺源远流长,每一件作品都蕴含着深厚的文化内涵。对于喜爱传统文化和手工艺品的游客来说,这里绝对是一个值得去的地方。

与自然融为一体的美景

木渎花苑街位于苏州木渎古镇的中心地带,周围环绕着翠绿的湖泊和青山。这里的景色非常优美,吸引了许多摄影爱好者和自然爱好者。漫步在这片美丽的自然环境中,你可以享受清新的空气、欣赏湖泊的倒影和青山的美景。

此外,木渎花苑街附近还有一些著名的景点,如木渎花博园和木渎湿地公园。这些景点提供了更多的自然资源和休闲娱乐设施,使游客可以更好地享受大自然的美。

文化活动和节庆庆典

木渎花苑街还定期举办一些文化活动和节庆庆典,吸引了大量游客和当地居民。例如,每年的花会期间,街道上会摆满各式各样的鲜花和花灯,各种表演和活动也会同时进行。这个时候,整个街区都洋溢着喜庆和热闹的气氛。

此外,木渎花苑街还有一些传统的节庆活动,如端午节的龙舟比赛、中秋节的赏月活动等。参与其中,你可以亲身体验到中国传统的文化氛围,感受到传统节庆的气氛。

总结

木渎花苑街以其悠久的历史、独特的文化景观和与自然融为一体的美景而吸引了众多游客。无论是对传统文化的热爱、自然风光的欣赏还是参与文化活动的喜好,这个古老的街区都能满足你的需求。因此,木渎花苑街仍然值得游客前来探索与享受。


(责编:admin)

分享让更多人看到

Asia Cell & Gene Therapy Innovation Summit 2024
  • Apr. 2nd - 3rd 2024
  • Shanghai, China

CGT Asia 2024 - The 5th Asia Cell & Gene Therapy Innovation Summit 2024
3DCC 2024 - The 2nd 3D Cell Culture and Organoid R&D Summit
CGT Awards - 2024 Asia Pacific Cell and Gene Therapy Innovation Star of the Year Award

0 +

Keynote
Speeches

0 +

Professional
Attendees

0 +

Featured
Booths

0 +

Global Cell&Gene
Therapy Enterprises

0 +

Media
Reports

Key words of the conference

Commercialization and Innovative Drug Access to Hospitals, Clinically Oriented and Innovative Therapies, Stem Cell Therapy, Extracellular Vesicles Therapy, MSC EV, Cell Therapy, Gene Therapy, RNA Therapy, Oncolytic Virus, Rare Disease, Tumor Microenvironment, Non-coding RNAs, Epigenetic, Single-Cell Sequencing, Biomarkers, Universal Cancer only Maker (UCOM), Immune Cell, TCR-T, CAR-NK, 3D Cell Culture, Organoid Model, CRISPR/CAS9 Gene Editing, iPSC, PCR, High-Throughput Screening, Application Plans,Continuous Production Process, GMP, AAV, (Non-) Viral Vectors, LNP etc.

Chips-on-Organoid, Microfluidic Technology, 3D Bio-Printing,Organoid vascularization, Advances in Cutting-Edge Technologies, Standardization and Application Scenarios, Clinical Research Applications, Drug Sensitivity Screening, R&D Applications, Efficacy Study, Cross-Cutting Technologies, Regenerative Medicine, Discussions on Laws and Regulations, etc.

Topics Highlights
The 5th Asia Cell and Gene Therapy Innovation Summit 2024
  • Case Study of Marketed Targeting CD19 CAR-T Cell Therapy Clinical Trials

  • Progress of Clinical Research on Mesenchymal Stem Cell Therapy for End-Stage Liver Disease

  • Highlights of Before and After Marketing Changes for Cell Therapy Drugs

  • Top CDMO Takes Your Cell Culture from Customization to Global Standardization

  • Role and Mechanisms of Cardiac-Derived Exosomes in Oncological Cardio Therapy

  • Bring In or Going Overseas--How to Accelerate the Commercialization of Cell Therapy?

  • Recent Clinical Advances in Gene Therapy for Hereditary Deafness

  • Novel Malignant Tumor Therapeutic Strategy - Lysovirus Enhances The Anti-Tumor

    Effect of DC Vaccines

  • Efficient Dual AAV Carrier Development Optimization and Design

  • Application and Progress of Small Nucleic Acid Drugs in The Field of Chronic Diseases

    such as Cardiovascular Diseases

  • ......

2024 3D Cell Culture Organoid R&D Summit

  • Regenerative Medicine Through The Eyes of An Investor

  • Microfluidic Chip-Assisted Vascularisation of Human Brain Organoids

  • Construction of Novel Human Endometrial Organoids

  • Research on Human Bionic Organoid and Organ-on-a-Chip Based on Neural Innervation

  • Clinical Case Sharing of Heart Transplantation for Heart Failure

  • Quality Control of Organoid Drug Sensitivity Testing Throughout the Entire Process

  • ......


At a Glance

3-2312121626223a.png


3-231120145302209.png

Exhibition & Show
Exhibition & Show
Exhibition & Show
Exhibition & Show
Exhibition & Show
Exhibition & Show
Exhibition & Show


Part of Speakers

Prof. Xinhua LIN
Prof. Xinhua LIN

President

School of Life Sciences Fudan University /  Greater Bay Area Institute of Precision Medicine

Prof. Zibing JIN
Prof. Zibing JIN

Deputy President of Beijing Tongren Hospital

Beijing Tongren Hospital Capital Medical University, Beijing Institute of Ophthalmology

Prof. Cheng QIAN
Prof. Cheng QIAN

CSO

Precision Biotech

Prof. Wei ZUO
Prof. Wei ZUO

Chairman

Regend Therapeutics

Prof. Hao SHEN
Prof. Hao SHEN

CSO

FOSUNKite

Dr. Maryland Franklin
Dr. Maryland Franklin

VP

Labcorp

Dr. Aron  JAFFE
Dr. Aron JAFFE

SVP

Chroma Medicine

Prof. Jonathan  Yuin-Han LOH
Prof. Jonathan Yuin-Han LOH

Director

A*STAR IMCB

Dr. Noriyasu ISHIKAWA
Dr. Noriyasu ISHIKAWA

CEO

Solallis Bio Inc.

Dr. David DU
Dr. David DU

Co-founder, CEO

Evergreen Therapeutics

Prof. Hongming HU
Prof. Hongming HU

CSO

ImmuXell

Prof. Guoying ZHOU
Prof. Guoying ZHOU

Chairman & CEO

ImmVira

Dr. Joan SHEN
Dr. Joan SHEN

Founder & CEO

NeuShen Tx

prof. Wenbin Qian
prof. Wenbin Qian

Founder

Rongu bio

Dr. Cecilia ZHANG
Dr. Cecilia ZHANG

CSO

Biosyngen

Mrs. Lanlin WU
Mrs. Lanlin WU

CEO

Carcell Biopharma Ltd.

Dr. Baohong ZHANG
Dr. Baohong ZHANG

CEO

Epigenic Therapeutics, Inc.

Dr. Minmin SUN
Dr. Minmin SUN

Chairman & CEO

Immunofoco

Prof. Alex H. Chang
Prof. Alex H. Chang

CEO

YaKe Biotech

Dr. Huashun LI
Dr. Huashun LI

Chairman

Ascle Therapeutics

Mr. Zhenhua Luo
Mr. Zhenhua Luo

PI

The First Affiliated Hospital of Sun Yat-sen University

Prof. Peng LIU
Prof. Peng LIU

Prof

Tsinghua university

Dr. Adam ZHAO
Dr. Adam ZHAO

Founder

Anlongbio

Dr. Binghe TAN
Dr. Binghe TAN

Co-Partner, Vice President of Production and CMC

BRL Medicine Inc.

Prof. Guoqiang HUA
Prof. Guoqiang HUA

Founder of D1 Medical

D1 MEDICAL TECHNOLOGY

Dr. Jun Li
Dr. Jun Li

CEO

Fundamentatx

Prof.  Bing Zhao
Prof. Bing Zhao

Prof

fudan university

Dr. Yuan CAI
Dr. Yuan CAI

CEO/Co-Founder

Starrygene Therapeutics

PI. Liang Li
PI. Liang Li

PI

southern medical university

Dr. Xiaofang Tang
Dr. Xiaofang Tang

Dr

GBA-IPM

Dr. Yi JIN
Dr. Yi JIN

CEO

GeCell Therapeutics

Mr. Zhihui Weng
Mr. Zhihui Weng

vp

sharecaptal

Dr. Libo ZHAO
Dr. Libo ZHAO

CTO

Echo Biotech

Dr. Andrew LIN
Dr. Andrew LIN

CEO

Lingyi Biotech Co., Ltd.

Dr. Yarong LIU
Dr. Yarong LIU

Founder/CEO

Grit Biotechnology

Dr. Wenmin ZHU
Dr. Wenmin ZHU

Marketing Director

T&L Biotechnology

Prof. Donghui ZHANG
Prof. Donghui ZHANG

Prof

Hubei university

Dr. Lang Zhang
Dr. Lang Zhang

Head of CMC-PD mRNA, in vivo Platform

CorrectSequence Therapeutics

Mr. Yun LIU
Mr. Yun LIU

Chairman/President

Huayi Capital/Huayi Research Institute

Dr. Yu ZHANG
Dr. Yu ZHANG

Founder/CEO

VCANBIO Life Science

Dr. ZhengBo SU
Dr. ZhengBo SU

Chairman

TCRCure Biopharma Ltd.

Dr. Junjie PENG
Dr. Junjie PENG

Chief Physician, Colorectal Surgery

Fudan University Shanghai Cancer Center

Dr. Ming YUAN
Dr. Ming YUAN

Chairman

Huayaokangming

Dr. Ying ZHANG
Dr. Ying ZHANG

Co-founder, CTO

Nuwacell

Dr. Xiang LI
Dr. Xiang LI

Chairman&Founder&CEO

XellSmart

Dr. Qiang CHEN
Dr. Qiang CHEN

CTO

DanausGT

Dr. Xueliang YU
Dr. Xueliang YU

VP

Starna Therapeutics

Mr. Gang LU
Mr. Gang LU

vp

shlifestemcell

Mrs. Zhong ZHAO
Mrs. Zhong ZHAO

BU Head & Chief Product Officer

DXY Insight Database

Dr. Wee Kiat TAN
Dr. Wee Kiat TAN

Co-CEO & COO

CytoMed Therapeutics

Dr. Xuedong DAI
Dr. Xuedong DAI

VP

collectively known as SAFE GLP

Mr. Victor YU
Mr. Victor YU

Country Manager of Greater China

Astrea Bioseparations Ltd

Dr. Lifan WEI
Dr. Lifan WEI

Senior Investigator

INADRD, CSPC

Dr. Zhou LI
Dr. Zhou LI

CSO

Juventas Cell Therapy LLC

Mr. Jack ZHANG
Mr. Jack ZHANG

Strategy and Business Development Lead, CGT APAC

Lonza

Dr. Zhao ZHU
Dr. Zhao ZHU

Co-founder/Chairman/CEO

Neuregen Therapeutics

Dr. Ramin BAGHIRZADE
Dr. Ramin BAGHIRZADE

Global Head Commercial – Gene Therapy CDMO Services

Charles River丨Biologics Solutions

Dr. Wenji DONG
Dr. Wenji DONG

Founder & Chairman

Genmedicn

Dr. Forrest CHEN
Dr. Forrest CHEN

CSO

Zhongying Biomedical

Dr. Gaofeng ZHA
Dr. Gaofeng ZHA

CEO

MagicRNA

Mrs. Wendy LIN
Mrs. Wendy LIN

Key Account Manager

EMBALL'ISO

 Mr.Gary Wang
Mr.Gary Wang

General Manager

kanglitai

Dr. Yang YANG
Dr. Yang YANG

CEO

Genevector Biotech

Dr. Jing FAN
Dr. Jing FAN

Founder & CEO

Hopstem

Mr. Zebin LING
Mr. Zebin LING

CEO

MingCeler

Dr. Ling PENG
Dr. Ling PENG

Medical Director

TCRcure

Prof. Hua LIU
Prof. Hua LIU

Founder, Chief Scientific Officer

Xinghua Bio

Dr. Fan MO
Dr. Fan MO

Co-founder & CEO

Neoantigen

Dr. Xinpo JIANG
Dr. Xinpo JIANG

Associate Vice President of R&D

GenScript

Mrs. Gloria Teng
Mrs. Gloria Teng

Executive Partne

GTJA Investment

Prof. Shuhang WANG
Prof. Shuhang WANG

Attending Doctor

CANCER HOSPITAL CHINESE ACADEMY OF MEDICAL SCIENCE

Mr. Alex CHENG
Mr. Alex CHENG

General Manager

Tofflon

Prof. Zhiyong ZHANG
Prof. Zhiyong ZHANG

Awardee of the First Prize of National Science and Technology Progress Award of China (Top scientific awards in China);Expert of National Talent Program of China;Chief Scientist of REGEN-αGEEK

REGEN-αGEEK

Dr. Luke LI
Dr. Luke LI

BD and Commercial VP

Neurophth Therapeutics

Mrs. Emily TAN
Mrs. Emily TAN

Chief Operating Officer

Unixell Biotechnology

Prof. Mi LIU
Prof. Mi LIU

Founder

Es-Bio

Dr. Hexige Saiyin
Dr. Hexige Saiyin

Assistant professor

Fudan University

Prof. Tianqing LI
Prof. Tianqing LI

Prof

Kunming University of Science and Technology

Dr. Zaozao CHEN
Dr. Zaozao CHEN

CTO

Avatarget

Mr. Chilin WU
Mr. Chilin WU

Partner

DeHeng

Prof. Jie LIU
Prof. Jie LIU

Principal scientist

Eacin Bio

Dr. Lei WANG
Dr. Lei WANG

Department Head of the Cell Resources Center of the National Stem Cell Resource Center

Institute of Zoology, Chinese Academy of Sciences/Beijing Institute of Stem Cell and Regenerative Medicine

Dr. Yi ZHOU
Dr. Yi ZHOU

COO

AimingMed

Prof. Hongju MAO
Prof. Hongju MAO

PI

Shanghai Institute of Microsystems and Information Technology, Chinese Academy of Sciences

Prof. Huaying CHEN
Prof. Huaying CHEN

Prof

Harbin Institute of Technology

Mrs. Katie LI
Mrs. Katie LI

Head of Clinical Operation

CorrectSequence Therapeutics

Dr. Yan XU
Dr. Yan XU

VP

Binhui Biopharm



More guests will continue to update them

Ways to Attend

Increase Your Visibility. Improve Your Reputation

Normal Ticket

  • 1 Pass

  • 2 Networking Buffet Lunch

  • Simultaneous Interpretation

  • PPTs & Documentation


Exhibition Sponsor

  • 3 Passes

  • 6㎡or 9㎡ Booth for show

  • Holistic Logo Branding On-site

  • 2 Networking Buffet Lunch

  • Simultaneous Interpretation

  • PPTs& Documentation


Presentation Sponsor

( Slots Limited)

  • 5 Passes

  • 30 min Speech Opportunity

  • 1 Color AD Page

  • Panelist Discussion

  • Holistic Logo Branding On-site

  • 2 Networking Buffet Lunch

  • Simultaneous Interpretation

  • PPTs& Documentation


Gold Sponsor

(Exclusive)

  • 5 or More Passes

  • 30 min Speech Opportunity

  • 6or 9 Booth for show

  • Chairman Opportunity

  • 1 Color AD Page

  • Panelist Discussion

  • Holistic Logo Branding On-site

  • 2 Networking Buffet Lunch

  • Simultaneous Interpretation

  • PPTs& Documentation


Secure your ticket today

Early Bird tickets available now

Secure your spot at CGT Asia our special offer, and don’t go alone, enjoy the best group discount.

Register

Sponsors & Partners

Part of Previous Sponsors

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
26

Part of Media Partners

今日头条
搜狐
药智网
医谷网
CPHI制药在线
会会药咖
镁客网
广动医谷
丁香会议
研发客
肽度
大健康派
生物探索
药源网
基因线上
转化医学网
现代健康网
医药健闻
中国制药设备网
细胞知聊
新康界
医诺医学
美通社
动脉网
医疗器械创新网
新浪医药
中国仪器批发网
细胞世界
戊戌数据
大健康网
嘉裕检测
肽研社
测序宝
基因君
猎药人
化学网
爱爱医
来宝网
生物咖啡茶
生物通
医学信息
中国生物器材网
分析测试百科网
全球医学会议网

Related Meetings

Presentation, Sponsorship and Exhibition

Gina Xu

Tel:86 21 5893 3801 ext.805

Mob:13601679417

Email:gina.xu@taaslabs.com

Media and Marketing Cooperation

Koala Yan

Tel:86 215893 3801 ext. 811

Mob:13341683667

Email:koala.yan@taaslabs.com

Know More Hot and informative Medical News on Biopharma, Cell& Gene etc. Follow Us Now